Maduro Medical, Inc. appears in FDA records at 983 University Avenue, Building A, Los Gatos, California, the address listed on its 510(k) correspondence. The supplied filings link the applicant to the Radical 064 and Radical 076 Reperfusion Catheters and the Radical Aspiration Tubing Kit, cleared under K261089 with a September 14, 2026 decision date and an April 1, 2026 receipt date. The submission was a Traditional 510(k) reviewed by the Cardiovascular advisory committee, with a summary statement and no third-party review. A separate clearance, K253975, covers the Radical 6F Access Catheter. [1][2][7]

The K261089 clearance and its device scope

K261089 covers three named items under product code NRY, classified as Catheter, Thrombus Retriever within the cardiovascular medical specialty. FDA recorded the decision as SESE, substantially equivalent, dated September 14, 2026, with the submission received April 1, 2026. The clearance type is listed as Traditional, the third-party flag as N, and the statement or summary field as Summary. [1][3][8]

The FDA clearance letter restates the trade name, regulation number 21 CFR 870.1250 for Percutaneous Catheter, Class II, and product code NRY, and is addressed to Janice Kemp, Director RA/QA, at the Los Gatos address. The letter is dated September 14, 2026 and references a submission dated August 5. [2]

Documented materials and kit components

The K261089 documentation lists catheter shaft materials as polyurethane, Pebax and nylon, with an inner liner of PTFE, described against polymers and metals commonly used in medical device manufacture. The same record names kit contents including an introducer catheter, peel-away introducers, RHV, aspiration tubing, a delivery catheter, a sheath, a dilator and a navigating catheter. [2]

An independent index of the clearance describes the submission as three items under product code NRY and notes that the record carries no further detail beyond that scope. That index states it is unofficial and independent of the FDA. [8]

Earlier and related filings

A separate FDA substantial equivalence determination, K253975 dated April 9, 2026, covers the Radical 6F Access Catheter under 21 CFR 870.1250, Class II, with product codes QJP and DQY. That document names the Radical the Dude 7F Guide Catheter (K231393) as predicate and lists the device's stated indication as introduction of intravascular catheters into the peripheral, coronary and neuro vasculature. [7]

A third-party FDA index lists registered device listings for Maduro Medical, Inc. tied to K261089, and separately lists Radical the Dude 8F Guide Catheter with a 2025-01-14 date and Radical the Dude 7F Guide Catheter with a 2023-11-30 date. That index states it aggregates public FDA datasets and legacy records and advises verifying critical decisions with official FDA sources. [5]

Applicant identity and attributed announcements

The supplied collection for this profile contains one linked 510(k) record, K261089, with a decision count of one SESE; the record sample likewise holds that single entry. These figures describe the MedtechLedger snapshot only and are not measures of total portfolio, sales or safety performance. [1]

A November 17, 2026 announcement published by Radical Catheter Technologies states that FDA granted 510(k) clearance for its Radical 076 and 064 Reperfusion Catheters and describes the company as a NeuroTechnology Investors portfolio company. That ownership and brand framing comes from the publisher, not from the FDA applicant record, which names Maduro Medical, Inc. [4]